ECO Animal Health Group Plc engages in the manufacture and supply of pharmaceutical products for animal health. The firm is focused on improving the health and welfare of pigs and poultry. The company is engaged in developing and marketing branded veterinary pharmaceuticals globally, in antibiotics and vaccines for pigs and poultry. The firm is focused on providing solutions to respiratory and enteric diseases in pigs and poultry. Its segment includes the United Kingdom, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World. The company provides products for swine and poultry to treat illness, improving health and performance. Its lead product, Aivlosin, is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. Aivlosin, which is sold in some markets under the tradename Valosin. The company also offers a range of products to treat parasites in cattle, sheep and pigs under the brand name Ecomectin.